Rohto-Mentholatum

Rohto Pharmaceutical, widely known as Rohto-Mentholatum, is a leading Japanese multinational corporation specializing in consumer healthcare, pharmaceuticals, and regenerative medicine. The company holds a dominant position in the global over-the-counter eye care market and owns the iconic Mentholatum brand, which it acquired in 1988. Rohto has strategically pivoted towards advanced biotechnology, establishing a robust platform for mesenchymal stem cell (MSC) therapies targeting unmet needs in liver disease, cardiology, and orthopedics. Its diverse portfolio includes popular skincare lines such as Hada Labo and Melano CC, alongside a clinical pipeline of cell-based therapeutics. With a strong presence across Asia, Europe, and the Americas, Rohto integrates traditional consumer health expertise with cutting-edge regenerative science.